Evidence map›Paper›PMID 41486930›Full record

ArticleJournal of microbiology (Seoul, Korea)2025

Multi-omic profiling reveals the impact of keratinase kerZJ on mouse gut homeostasis.

Xueqing Gan, Yijiao Wen, Si Chen, Famin Ke, Siyuan Liu, Zening Wang, Chunhua Zhang, Xuanting Wang, Qin Wang, Xiaowei Gao

Abstract read
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueqing GanDepartment of Cardiovascular Medicine, Xuyong People's Hospital, Luzhou 646400, P. R. China.
Yijiao WenGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Si ChenGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Famin KeGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Siyuan LiuGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Zening WangGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Chunhua ZhangGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Xuanting WangGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.
Qin WangDazhou Vocational College of Chinese Medicine, Dazhou 635000, P. R. China.
Xiaowei GaoGreen Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, P. R. China.

Funding

Open Fund of State Key Laboratory of Neurology and Oncology Drug Development SKLSIM-F-202458Phoenix Project of Dazhou DZFHXM202318Science and Technology Program of Sichuan province 2024NSFSC2097Science and Technology Strategic Cooperation Program of Luzhou Municipal Peoples Government and Southwest Medical University 2024LZXNYDJ054Strategic Cooperation program of Xuyong County Peoples Hospital and Southwest Medical University 2023XYXNYD06
6 · The paper itself

Abstract

Keratinase kerZJ is a multifunctional protease with potential as a feed additive and functional ingredient. Here we performed an integrated multi‑omics evaluation of its biosafety and impact on gut homeostasis in mice. Our findings confirm that kerZJ is well-tolerated, with no evidence of systemic toxicity or intestinal epithelial damage. Integrated transcriptomic and proteomic analyses revealed that kerZJ reinforces intestinal barrier integrity by upregulating extracellular matrix components, including collagen IV, and modulates mucosal immunity by enhancing B-cell activation and antimicrobial peptide defenses without inducing inflammation. Furthermore, kerZJ administration led to a significant upregulation of digestive enzymes and a dose-dependent increase in short-chain fatty acids production. Microbiome analysis showed that while high-dose kerZJ altered community composition, it enriched for beneficial taxa like Lactobacillaceae and did not induce dysbiosis. These results demonstrate that kerZJ safely enhances gut barrier function, promotes a favorable immune and metabolic environment, and fosters a resilient gut ecosystem, supporting its development as a safe feed additive and nutraceutical component.

Indexed as

Gastrointestinal MicrobiomeHomeostasisPeptide HydrolasesAnimalsFatty Acids, VolatileImmunity, MucosalIntestinal MucosaMaleMiceMice, Inbred C57BLMultiomicsProteomicsFatty Acids, VolatilekeratinasePeptide Hydrolasesfeed additivegut microbiotakeratinaseproteometranscriptome

Identifiers

PMID41486930
PMCPMC13577124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.